Marco Londei

Title: Marco Londei: Innovator in Immunology

Introduction

Marco Londei is a prominent inventor based in San Diego, CA (US). He has made significant contributions to the field of immunology, particularly through his innovative work on antibodies directed against the interleukin 36 receptor (IL-36R). With a total of 3 patents, Londei's inventions are paving the way for new treatments in various medical conditions.

Latest Patents

Londei's latest patents include groundbreaking inventions that focus on the IL-36R. One of his notable patents is for antibodies directed against IL-36R, which involves isolated immunoglobulin heavy chain and light chain polypeptides that bind to the IL-36R protein. This invention provides an IL-36R-binding agent that can be utilized in vectors, compositions, and methods aimed at treating disorders responsive to IL-36R inhibition, such as cancer, infectious diseases, and autoimmune diseases. Another significant patent addresses the method of treating pustular psoriasis using these antibodies, further showcasing his commitment to advancing medical science.

Career Highlights

Marco Londei is currently associated with Anaptysbio, Inc., where he continues to innovate and develop new therapeutic solutions. His work has been instrumental in enhancing our understanding of immune responses and developing targeted treatments.

Collaborations

Londei collaborates with esteemed colleagues, including Andrew John McKnight and David J King, to further his research and development efforts in immunology.

Conclusion

Marco Londei's contributions to the field of immunology through his patents and collaborations highlight his role as a key innovator. His work not only advances scientific knowledge but also holds the potential to improve treatment options for various diseases.